CIENCIAS BIOMÉDICAS Y DEL DIAGNÓSTICO
Saila
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoAstraZeneca (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2019
-
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
The Lancet Respiratory Medicine, Vol. 7, Núm. 1, pp. 46-59